Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus

BACKGROUND: The CC genotype of the IFNL4 gene is known to be associated with increased Hepatitis C (HCV) cure rates with interferon-based therapy and may contribute to cure with direct acting antivirals. The Genedrive® IFNL4 is a CE marked Point of Care (PoC) molecular diagnostic test, designed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sy, Aminata, McCabe, Leanne, Hudson, Emma, Ansari, Azim M., Pedergnana, Vincent, Lin, Shang-Kuan, Santana, S., Fiorino, Marzia, Ala, Aftab, Stone, Ben, Smith, M., Nelson, Mark, Barclay, Stephen T., McPherson, Stuart, Ryder, Stephen D., Collier, Jane, Barnes, Eleanor, Walker, Ann Sarah, Pett, Sarah L., Cooke, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870125/
https://www.ncbi.nlm.nih.gov/pubmed/36689413
http://dx.doi.org/10.1371/journal.pone.0280551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870125/
https://www.ncbi.nlm.nih.gov/pubmed/36689413
http://dx.doi.org/10.1371/journal.pone.0280551

Ejemplares similares